MINI REVIEW
Accepted on 19 May 2025
Lymphatic dissemination of HPV-positive oropharyngeal squamous cell carcinoma (OPSCC): underlying mechanisms and treatment innnovations
doi 10.3389/fimmu.2025.1601572
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Harnessing Molecular Insights for Enhanced Drug Sensitivity and Immunotherapy in Cancer
Harnessing Molecular Insights for Enhanced Drug Sensitivity and Immunotherapy in Cancer
13k
Total downloads
51k
Total views and downloads
Articles
ORIGINAL RESEARCH
Accepted on 15 May 2025
TMEM115: a promising marker for glioma immunotherapy and prognosis
doi 10.3389/fimmu.2025.1598499
- 138 views
ORIGINAL RESEARCH
Published on 13 May 2025
MYB Proto-Oncogene Like 2 identified as a biomarker for uterine corpus endometrial carcinoma: evidence from bioinformatics and clinical validation
doi 10.3389/fonc.2025.1595485
- 450 views
ORIGINAL RESEARCH
Accepted on 12 May 2025
Exploring and validating a guanylate-binding protein signature to predict the prognostic features of patients with lung adenocarcinoma
doi 10.3389/fimmu.2025.1588663
- 163 views
ORIGINAL RESEARCH
Accepted on 09 May 2025
Risk scoring model for lung adenocarcinoma based on PD-L1 related signature reveals prognostic predictability and correlation with tumor immune microenvironment. genes was constructed
doi 10.3389/fimmu.2025.1601982
ORIGINAL RESEARCH
Accepted on 07 May 2025
Identification of anoikis-related subtypes and a risk score prognosis model, the association with TME landscapes and therapeutic responses in hepatocellular carcinoma
doi 10.3389/fimmu.2025.1602831
ORIGINAL RESEARCH
Published on 05 May 2025
TNFRSF12A expression in stomach adenocarcinoma and its preliminary role in predicting immunotherapy response
doi 10.3389/fimmu.2025.1578068
- 794 views
ORIGINAL RESEARCH
Accepted on 01 May 2025
Single-Cell Ligand-Receptor Profiling Reveals an Immunotherapy-Responsive Subtype and Prognostic Signature in Triple-Negative Breast Cancer
doi 10.3389/fimmu.2025.1590951
- 229 views
ORIGINAL RESEARCH
Accepted on 22 Apr 2025
Circular RNA KIF18A promotes the progression of hepatocellular carcinoma by sponging miR-622 and upregulating CCNB1
doi 10.3389/fonc.2025.1594530
- 174 views
ORIGINAL RESEARCH
Published on 17 Apr 2025
The malignant signature gene of cancer-associated fibroblasts serves as a potential prognostic biomarker for colon adenocarcinoma patients
doi 10.3389/fimmu.2025.1589678
- 1,000 views
ORIGINAL RESEARCH
Published on 16 Apr 2025
Identification of the gene signatures related to NK/T cell communication to evaluate the tumor microenvironment and prognostic outcomes of patients with prostate adenocarcinoma
doi 10.3389/fimmu.2025.1564784
- 898 views
MINI REVIEW
Published on 08 Apr 2025
The role of tumor-associated macrophages in HPV induced cervical cancer
doi 10.3389/fimmu.2025.1586806
- 1,441 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore